NewsBite analysis · Business
Financial Times
SpaceX and the myth of independent Wall St research
Following SpaceX's IPO, major banks have published their research recommending the stock while presenting varying price targets, casting doubt on the authenticity of their analyses. The article reflects on the history of Wall Street research independence reforms initiated by Eliot Spitzer, suggesting that while overt conflicts may have been addressed, underlying incentives remain unaltered. Investors often distrust sell-side research, favoring company data and access to management, which leads to a reliance on flatteringly optimistic reports that affirm company narratives.
MonitorConfidence: HighImmediate horizon
Published 18 Jul 2026, 00:40 UTC4 min read
Visit original article ↗Lead image — Financial Times
Summary
TL;DR
- Goldman Sachs sets SpaceX share price target at $205.
- Morgan Stanley and Raymond James present targets of $300 and $800 respectively.
- Current share price is approximately $125, raising skepticism about the suggested valuations.
- Reforms post-dot-com bubble have not entirely eliminated biases in research.
- Management teams favor positive research, which may compromise analyst objectivity.
Interesting facts
- SpaceX’s IPO has led to a stark contrast between bullish bank predictions and the actual market response.
- Despite regulatory changes, analysts may still reflect the desires of investment bankers due to intertwined incentives.